Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Adverse reactions to calcium antagonists.

Literature DB >> 6339200

Adverse reactions to calcium antagonists.

J G Lewis.

Abstract

Entities: Chemical

Mesh：

Substances：

Year: 1983 PMID： 6339200 DOI： 10.2165/00003495-198325020-00006

Source DB: PubMed Journal: Drugs ISSN： 0012-6667 Impact factor: 9.546

× No keyword cloud information.

105 in total

1. Asystole after verapamil.

Authors: M E Benaim
Journal: Br Med J Date: 1972-04-15

2. Drugs and the heart. III. Calcium antagonists.

Authors: L H Opie
Journal: Lancet Date: 1980-04-12 Impact factor: 79.321

3. Adverse interaction between nifedipine and beta-blockade.

Authors: J S Staffurth; P Emery
Journal: Br Med J (Clin Res Ed) Date: 1981-01-17

4. Calcium for myocardial depression from verapamil.

Authors: V T Hattori; W J Mandel; D Peter
Journal: N Engl J Med Date: 1982-01-28 Impact factor: 91.245

5. Hepatotoxicity due to treatment with verapamil.

Authors: S J Brodsky; S S Cutler; D A Weiner; M D Klein
Journal: Ann Intern Med Date: 1981-04 Impact factor: 25.391

6. Clinical efficacy of verapamil alone and combined with propranolol in treating patients with chronic stable angina pectoris.

Authors: M B Leon; D R Rosing; R O Bonow; L C Lipson; S E Epstein
Journal: Am J Cardiol Date: 1981-07 Impact factor: 2.778

7. Treatment of hypertension with nifedipine, a calcium antagonistic agent.

Authors: M T Olivari; C Bartorelli; A Polese; C Fiorentini; P Moruzzi; M D Guazzi
Journal: Circulation Date: 1979-05 Impact factor: 29.690

8. Impairment of insulin secretion in man by nifedipine.

Authors: D Giugliano; R Torella; F Cacciapuoti; S Gentile; M Verza; M Varricchio
Journal: Eur J Clin Pharmacol Date: 1980-11 Impact factor: 2.953

9. Verapamil in the long-term treatment of angina pectoris.

Authors: J Raftos
Journal: Med J Aust Date: 1980-07-26 Impact factor: 7.738

10. Verapamil in the management of supraventricular tachyarrhythmias occurring after a recent myocardial infarction.

Authors: F Hagemeijer
Journal: Circulation Date: 1978-04 Impact factor: 29.690

16 in total

Review 1. Treating hypertension in older adults: safety considerations.

Authors: Wilbert S Aronow
Journal: Drug Saf Date: 2009 Impact factor: 5.606

Review 2. Nifedipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy, in ischaemic heart disease, hypertension and related cardiovascular disorders.

Authors: E M Sorkin; S P Clissold; R N Brogden
Journal: Drugs Date: 1985-09 Impact factor: 9.546

Review 7. Verapamil. An updated review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension.

Authors: D McTavish; E M Sorkin
Journal: Drugs Date: 1989-07 Impact factor: 9.546

Adverse reactions to calcium antagonists.

1. Asystole after verapamil.

2. Drugs and the heart. III. Calcium antagonists.

3. Adverse interaction between nifedipine and beta-blockade.

4. Calcium for myocardial depression from verapamil.

5. Hepatotoxicity due to treatment with verapamil.

6. Clinical efficacy of verapamil alone and combined with propranolol in treating patients with chronic stable angina pectoris.

7. Treatment of hypertension with nifedipine, a calcium antagonistic agent.

8. Impairment of insulin secretion in man by nifedipine.

9. Verapamil in the long-term treatment of angina pectoris.

10. Verapamil in the management of supraventricular tachyarrhythmias occurring after a recent myocardial infarction.

Review 1. Treating hypertension in older adults: safety considerations.

Review 2. Nifedipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy, in ischaemic heart disease, hypertension and related cardiovascular disorders.

3. Inter- and intra-subject variability of nitrendipine and the effects of food.

4. Organic psychosis caused by diltiazem.

5. Calcium channel blockers and the emergency care kit in the dental office.

6. Chest pain after captopril.

Review 7. Verapamil. An updated review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension.

8. Plasma levels and myocardial content of verapamil, norverapamil and two N-dealkyl-metabolites in man.

Review 9. Poisoning due to calcium antagonists. Experience with verapamil, diltiazem and nifedipine.

Review 10. The effect of antihypertensive treatment on the quality of later years.